Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

News

News
MindMed Releases Positive Topline Results in Study of LSD Treating Anxiety Disorders
05/23/2022
MindMed, clinical stage biopharmaceutical developer of products to treat brain health disorders, has announced its collaborators at University Hospital Basel in Switzerland, have released positive topline data from a Phase II...
MindMed, clinical stage biopharmaceutical developer of products to treat brain health disorders, has announced its collaborators at University Hospital Basel in Switzerland, have released positive topline data from a Phase II...
MindMed, clinical stage...
05/23/2022
Psych Congress Network
News
Researchers to Study Use of Ibogaine to Treat Methadone Withdrawal Symptoms
05/20/2022
ICEERS has partnered with Sant Joan de Reus University Hospital to conduct a clinical trial of a novel ibogaine treatment protocol to support patients tapering off methadone.
ICEERS has partnered with Sant Joan de Reus University Hospital to conduct a clinical trial of a novel ibogaine treatment protocol to support patients tapering off methadone.
ICEERS has partnered with Sant...
05/20/2022
Psych Congress Network
News
People With Dementia May Benefit From CBT for Depression
05/16/2022
Psychological interventions may improve depression and quality of life in people with dementia, according to an updated systematic review.
Psychological interventions may improve depression and quality of life in people with dementia, according to an updated systematic review.
Psychological interventions may...
05/16/2022
Psych Congress Network

Advertisement

News
Adolescent Substance Use, Mental Health Challenges Elevated Among Homeless Population
05/16/2022
Homeless adolescents in the US are more likely to have used cocaine, meth, or heroin than nonhomeless adolescents, according to a recent study.
Homeless adolescents in the US are more likely to have used cocaine, meth, or heroin than nonhomeless adolescents, according to a recent study.
Homeless adolescents in the US...
05/16/2022
Addiction Professional
News
Australian Firm Explores Use of VR in Psychedelic-Assisted Psychotherapy
05/12/2022
Enosis Therapeutics Co-Founder Agnieszka Sekula discusses the company’s integration of virtual reality into existing psychedelic-assisted therapy protocols.
Enosis Therapeutics Co-Founder Agnieszka Sekula discusses the company’s integration of virtual reality into existing psychedelic-assisted therapy protocols.
Enosis Therapeutics Co-Founder...
05/12/2022
Psych Congress Network
News
FDA Approves New Test for Early Detection, Diagnosis of Alzheimer Disease
05/09/2022
The US Food and Drug Administration (FDA) approved the first in vitro diagnostic test for the early detection of amyloid plaques.
The US Food and Drug Administration (FDA) approved the first in vitro diagnostic test for the early detection of amyloid plaques.
The US Food and Drug...
05/09/2022
Neurology

Advertisement

News
Pediatric Stroke Doubles ADHD Risk
05/09/2022
Pediatric ischemic stroke is associated with a 2-fold increased risk of attention-deficit/hyperactivity disorder (ADHD), according to a study published in JAMA Network Open.
Pediatric ischemic stroke is associated with a 2-fold increased risk of attention-deficit/hyperactivity disorder (ADHD), according to a study published in JAMA Network Open.
Pediatric ischemic stroke is...
05/09/2022
Psych Congress Network
News
Maladaptive Daydreaming Underlies Inattention for a Subgroup of Adults With ADHD
05/09/2022
A better diagnosis for some individuals categorized as having attention-deficit/hyperactivity disorder (ADHD) may be maladaptive daydreaming, suggests a study published in the Journal of Clinical Psychology.
A better diagnosis for some individuals categorized as having attention-deficit/hyperactivity disorder (ADHD) may be maladaptive daydreaming, suggests a study published in the Journal of Clinical Psychology.
A better diagnosis for some...
05/09/2022
Psych Congress Network
News
Mental Health Concerns Rising, but Confidence in Telehealth Increases as Well
05/05/2022
Mental health concerns remain on the rise among Americans over the age of 18, but more individuals now feel more comfortable seeking support and using telehealth-based interventions, according to new research from CVS Health and Morning...
Mental health concerns remain on the rise among Americans over the age of 18, but more individuals now feel more comfortable seeking support and using telehealth-based interventions, according to new research from CVS Health and Morning...
Mental health concerns remain on...
05/05/2022
Behavioral Healthcare Executive

Advertisement

News
Artificial Intelligence Analyzes Online Posts for Depressive Symptoms in Young People
05/02/2022
Artificial intelligence technology trained to analyze content in online posts written by young people demonstrated a 98% to 99% mean performance in detecting depression symptoms, according to a study published in the journal Neural Computing...
Artificial intelligence technology trained to analyze content in online posts written by young people demonstrated a 98% to 99% mean performance in detecting depression symptoms, according to a study published in the journal Neural Computing...
Artificial intelligence...
05/02/2022
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use